Pharma CEOs Urge Next FDA Commissioner to Restore Stability Amid Industry Turmoil
The pharmaceutical industry is calling for the next FDA commissioner to restore stability after months of turmoil, including leadership changes and st...
Xeber.world
drug pricing
- electric vehicles
- automotive industry
- Stellantis
- collector cars
- automotive history
- Limited Edition
- classic cars
- Mecum Auctions
- supercar
- Formula 1
- Donald Trump
- AI ethics
- U.S. China relations
- AI adoption
- AI regulation
- artificial intelligence
- Trump administration
- inflation
- AI governance
- AI in business
- Bitcoin
- crypto regulation
- Senate Banking Committee
- CLARITY Act
- digital assets
- Digital Asset Market Clarity Act
- Federal Reserve
- Bitcoin price
- Bitcoin ETF
- crypto market
- AI cybersecurity
- cybersecurity
- CISA
- enterprise security
- CVE-2026-41089
- CVE-2026-41096
- Canvas data breach
- Instructure
- House Homeland Security Committee
- Donald Trump
- Netflix
- late-night TV
- Disney
- Paramount
- Cannes Film Festival
- Stephen Colbert
- Prime Video
- Jimmy Kimmel
- Marvel
- climate change
- renewable energy
- energy policy
- AI data centers
- geothermal energy
- Fervo Energy
- U.S. energy policy
- Strait of Hormuz
- Jason Bordoff
- Texas drought
- Subnautica 2
- Phasmophobia
- gaming news
- R.E.P.O.
- Forza Horizon 6
- FC 26
- Subnautica 2 tips
- Subnautica 2 guide
- Alan Wake event
- Destructoid
- FDA
- public health
- Marty Makary
- Trump administration
- healthcare policy
- Kyle Diamantas
- hantavirus
- health policy
- FDA leadership
- gene therapy
- Donald Trump
- Trump administration
- Supreme Court
- gerrymandering
- Iran war
- Voting Rights Act
- 2024 election
- Republican Party
- Virginia Supreme Court
- redistricting
- AI ethics
- climate change
- Elon Musk
- OpenAI
- ChatGPT
- tech industry
- Tesla
- remote sensing
- AI in the workplace
- generative AI
Pharma Giants Spent $130M+ on Lobbying in 2025 for TrumpRx Drug Pricing Plan
Pharmaceutical companies backing TrumpRx spent over $130 million on federal lobbying in 2025, a 23% surge. Eli Lilly paused its obesity awareness camp...
Capricor Sues Nippon Shinyaku Over Delays and Pricing Flaw in Duchenne Drug Distribution Deal
Capricor Therapeutics has filed a lawsuit against Nippon Shinyaku and its U.S. subsidiary, NS Pharma, alleging they failed to execute marketing plans...
FDA Revisits Rare Cancer Drug Approval After Unexpected Rejection Sparks Controversy
The FDA is reconsidering its decision to reject a treatment for a rare cancer after an unexpected rejection. Meanwhile, experts question the Trump adm...
Trump Administration Unveils Most Favored Nation Drug Pricing Plan with $529 Billion Savings Claim
The Trump administration released a detailed report outlining its most favored nation drug pricing policy, projecting $529 billion in savings over a d...
PhRMA Launches $1M+ Ad Campaign Against 340B Drug Pricing Program; FDA Rejection Rates for Cell and Gene Therapies Surge
Pharmaceutical Research and Manufacturers of America (PhRMA) is launching a seven-figure ad campaign targeting the 340B Drug Pricing Program. Meanwhil...
Pharma Industry Reputation Improves Among Patient Groups, Yet Access and Pricing Concerns Persist
A new survey reveals that 57% of patient groups rated pharmaceutical companies' reputation as 'excellent' or 'good' in 2025, up from 56% in 2024. Whil...
Pharma Industry Warns Trump's Drug Pricing Policy Could Delay New Treatments Globally
Novartis CEO Vas Narasimhan warns that President Trump's most-favored-nation drug pricing policy could disrupt global drug access and delay new treatm...
Colorado and Virginia Legislatures Block Restrictions on Drug Affordability Boards
Legislators in Colorado and Virginia have rejected efforts to limit the power of Prescription Drug Affordability Boards, which set price caps on presc...
Pharmalittle: Rising Concerns Over Telehealth Fees and Drug Approval Controversies
Health policy experts and legislators are raising concerns over high fees paid by pharmaceutical companies to telehealth providers, potentially violat...
How a Patent Lawyer’s Work Shaped America’s High Drug Prices: The Story of Alfred Engelberg
Alfred Engelberg, a patent lawyer, played a pivotal role in shaping U.S. pharmaceutical policy. His work led to more generic drugs but also entrenched...